Equities

American Oncology Network Inc

AONC:QXR

American Oncology Network Inc

Actions
  • Price (USD)3.60
  • Today's Change0.55 / 18.03%
  • Shares traded4.66k
  • 1 Year change-42.31%
  • Beta0.3659
Data delayed at least 15 minutes, as of Nov 12 2024 20:39 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments643727
Total Receivables, Net165166138
Total Inventory453635
Prepaid expenses4.282.673.28
Other current assets, total--05.00
Total current assets278242208
Property, plant & equipment, net847633
Goodwill, net------
Intangibles, net1.231.231.11
Long term investments------
Note receivable - long term1.152.083.15
Other long term assets7.595.203.11
Total assets374326248
LIABILITIES
Accounts payable12810693
Accrued expenses363117
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.190.430
Other current liabilities, total4.332.839.23
Total current liabilities169141119
Total long term debt858264
Total debt868264
Deferred income tax------
Minority interest167----
Other liabilities, total50415.72
Total liabilities471264189
SHAREHOLDERS EQUITY
Common stock0.003636
Additional paid-in capital------
Retained earnings (accumulated deficit)(162)2623
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.08(0.12)0
Total equity(97)6260
Total liabilities & shareholders' equity374326248
Total common shares outstanding9.529.539.53
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.